Skip to main content
. 2020 Aug 2;8(2):e000668. doi: 10.1136/jitc-2020-000668

Figure 1.

Figure 1

Median overall survival (mOS) and median progression-free survival (mPFS) after infusion of tumor-infiltrating lymphocytes (TIL). Kaplan-Meier curves showing OS (A) and PFS (B) for the entire cohort (n=55).